Comprehensive characterisation of pulmonary and serum surfactant protein D in COPD

Respiratory Research

Volumn 12, Issue , 2011, Pages

  Winkler, Carla ^a,b   Atochina Vasserman, Elena N ^c   Holz, Olaf ^a   Beers, Michael F ^c   Erpenbeck, Veit J ^a,b   Krug, Norbert ^a   Roepcke, Stefan ^d   Lauer, Gereon ^d   Elmlinger, Martin ^d   Hohlfeld, Jens M ^a,b  

^a FRAUNHOFER INSTITUTE FOR TOXICOLOGY AND EXPERIMENTAL MEDICINE   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d Nycomed GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

SURFACTANT PROTEIN D; BIOLOGICAL MARKER;

ADULT; AEROBIC EXERCISE; AGED; ARTICLE; BRONCHOSCOPY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; CYCLING; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG LAVAGE; LUNG PARENCHYMA; MALE; OXIDATION; PROTEIN BLOOD LEVEL; PROTEIN CONTENT; PROTEIN MODIFICATION; PROTEIN QUATERNARY STRUCTURE; TISSUE LEVEL; ANALYSIS OF VARIANCE; BLOOD; CHEMISTRY; COLORIMETRY; CYTOLOGY; EXERCISE TEST; GERMANY; HOSPITALIZATION; LUNG; METABOLISM; MIDDLE AGED; OXIDATION REDUCTION REACTION; PATHOPHYSIOLOGY; PREDICTIVE VALUE; REPRODUCIBILITY; SMOKING; VITAL CAPACITY;

ADULT; AGED; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; BRONCHOALVEOLAR LAVAGE FLUID; COLORIMETRY; CROSS-SECTIONAL STUDIES; EXERCISE TEST; FEMALE; FORCED EXPIRATORY VOLUME; GERMANY; HUMANS; LUNG; MALE; MIDDLE AGED; OXIDATION-REDUCTION; PREDICTIVE VALUE OF TESTS; PROTEIN STRUCTURE, QUATERNARY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY SURFACTANT-ASSOCIATED PROTEIN D; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; SMOKING; VITAL CAPACITY; YOUNG ADULT;

EID: 79952477228     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-12-29     Document Type: Article

References (34)

1. Cosio MG, Saetta M, Agusti A. Immunologic aspects of chronic obstructive pulmonary disease. N Engl J Med 2009, 360:2445-2454. 10.1056/NEJMra0804752, 19494220.
2. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, Fukuchi Y, Jenkins C, Rodriguez-Roisin R, van Weel C, Zielinski J. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007, 176:532-555. 10.1164/rccm.200703-456SO, 17507545.
3. Wright JR. Immunoregulatory functions of surfactant proteins. Nat Rev Immunol 2005, 5:58-68. 10.1038/nri1528, 15630429.
4. Fisher JH, Sheftelyevich V, Ho YS, Fligiel S, McCormack FX, Korfhagen TR, Whitsett JA, Ikegami M. Pulmonary-specific expression of SP-D corrects pulmonary lipid accumulation in SP-D gene-targeted mice. Am J Physiol Lung Cell Mol Physiol 2000, 278:L365-L373.
5. Kishore U, Greenhough TJ, Waters P, Shrive AK, Ghai R, Kamran MF, Bernal AL, Reid KB, Madan T, Chakraborty T. Surfactant proteins SP-A and SP-D: structure, function and receptors. Mol Immunol 2006, 43:1293-1315. 10.1016/j.molimm.2005.08.004, 16213021.
6. Matalon S, Shrestha K, Kirk M, Waldheuser S, McDonald B, Smith K, Gao Z, Belaaouaj A, Crouch EC. Modification of surfactant protein D by reactive oxygen-nitrogen intermediates is accompanied by loss of aggregating activity, in vitro and in vivo. FASEB J 2009, 23:1415-1430. 10.1096/fj.08-120568, 2669423, 19126597.
7. Brown-Augsburger P, Chang D, Rust K, Crouch EC. Biosynthesis of surfactant protein D. Contributions of conserved NH2-terminal cysteine residues and collagen helix formation to assembly and secretion. J Biol Chem 1996, 271:18912-18919. 10.1074/jbc.271.31.18912, 8756121.
8. Gardai SJ, Xiao YQ, Dickinson M, Nick JA, Voelker DR, Greene KE, Henson PM. By binding SIRPalpha or calreticulin/CD91, lung collectins act as dual function surveillance molecules to suppress or enhance inflammation. Cell 2003, 115:13-23. 10.1016/S0092-8674(03)00758-X, 14531999.
9. Guo CJ, Atochina-Vasserman EN, Abramova E, Foley JP, Zaman A, Crouch E, Beers MF, Savani RC, Gow AJ. S-nitrosylation of surfactant protein-D controls inflammatory function. PLoS Biol 2008, 6:e266. 10.1371/journal.pbio.0060266, 2581630, 19007302.
10. Honda Y, Kuroki Y, Matsuura E, Nagae H, Takahashi H, Akino T, Abe S. Pulmonary surfactant protein D in sera and bronchoalveolar lavage fluids. Am J Respir Crit Care Med 1995, 152:1860-1866.
11. Ohnishi H, Yokoyama A, Kondo K, Hamada H, Abe M, Nishimura K, Hiwada K, Kohno N. Comparative study of KL-6, surfactant protein-A, surfactant protein-D, and monocyte chemoattractant protein-1 as serum markers for interstitial lung diseases. Am J Respir Crit Care Med 2002, 165:378-381.
12. Lomas DA, Silverman EK, Edwards LD, Locantore NW, Miller BE, Horstman DH, Tal-Singer R. Serum surfactant protein D is steroid sensitive and associated with exacerbations of COPD. Eur Respir J 2009, 34:95-102. 10.1183/09031936.00156508, 19164344.
13. Hermans C, Bernard A. Lung epithelium-specific proteins: characteristics and potential applications as markers. Am J Respir Crit Care Med 1999, 159:646-678.
14. Erpenbeck VJ, Schmidt R, Gunther A, Krug N, Hohlfeld JM. Surfactant protein levels in bronchoalveolar lavage after segmental allergen challenge in patients with asthma. Allergy 2006, 61:598-604. 10.1111/j.1398-9995.2006.01062.x, 16629790.
15. Koopmans JG, van der Zee JS, Krop EJ, Lopuhaa CE, Jansen HM, Batenburg JJ. Serum surfactant protein D is elevated in allergic patients. Clin Exp Allergy 2004, 34:1827-1833. 10.1111/j.1365-2222.2004.02083.x, 15663555.
16. Sims MW, Tal-Singer RM, Kierstein S, Musani AI, Beers MF, Panettieri RA, Haczku A. Chronic obstructive pulmonary disease and inhaled steroids alter surfactant protein D (SP-D) levels: a cross-sectional study. Respir Res 2008, 9:13. 10.1186/1465-9921-9-13, 2249580, 18226251.
17. Hirche TO, Crouch EC, Espinola M, Brokelman TJ, Mecham RP, DeSilva N, Cooley J, Remold-O'Donnell E, Belaaouaj A. Neutrophil serine proteinases inactivate surfactant protein D by cleaving within a conserved subregion of the carbohydrate recognition domain. J Biol Chem 2004, 279:27688-27698. 10.1074/jbc.M402936200, 15078883.
18. Starosta V, Griese M. Oxidative damage to surfactant protein D in pulmonary diseases. Free Radic Res 2006, 40:419-425. 10.1080/10715760600571248, 16517507.
19. Hoegh SV, Sorensen GL, Tornoe I, Lottenburger T, Ytting H, Nielsen HJ, Junker P, Holmskov U. Long-term stability and circadian variation in circulating levels of surfactant protein D. Immunobiology 2010, 215:314-320. 10.1016/j.imbio.2009.05.001, 19540617.
20. Thum T, Erpenbeck VJ, Moeller J, Hohlfeld JM, Krug N, Borlak J. Expression of xenobiotic metabolizing enzymes in different lung compartments of smokers and nonsmokers. Environ Health Perspect 2006, 114:1655-1661. 1665420, 17107849.
21. Beirne P, Pantelidis P, Charles P, Wells AU, Abraham DJ, Denton CP, Welsh KI, Shah PL, du Bois RM, Kelleher P. Multiplex immune serum biomarker profiling in sarcoidosis and systemic sclerosis. Eur Respir J 2009,
22. Atochina EN, Beck JM, Preston AM, Haczku A, Tomer Y, Scanlon ST, Fusaro T, Casey J, Hawgood S, Gow AJ, Beers MF. Enhanced lung injury and delayed clearance of Pneumocystis carinii in surfactant protein A-deficient mice: attenuation of cytokine responses and reactive oxygen-nitrogen species. Infect Immun 2004, 72:6002-6011. 10.1128/IAI.72.10.6002-6011.2004, 517574, 15385504.
23. Schagger H, von Jagow G. Blue native electrophoresis for isolation of membrane protein complexes in enzymatically active form. Anal Biochem 1991, 199:223-231. 10.1016/0003-2697(91)90094-A, 1812789.
24. Crouch E, Persson A, Chang D, Heuser J. Molecular structure of pulmonary surfactant protein D (SP-D). J Biol Chem 1994, 269:17311-17319.
25. Mori K, Kurihara N, Hayashida S, Tanaka M, Ikeda K. The intrauterine expression of surfactant protein D in the terminal airways of human fetuses compared with surfactant protein A. Eur J Pediatr 2002, 161:431-434. 10.1007/s00431-002-0917-9, 12172826.
26. Sin DD, Leung R, Gan WQ, Man SP. Circulating surfactant protein D as a potential lung-specific biomarker of health outcomes in COPD: a pilot study. BMC Pulm Med 2007, 7:13. 10.1186/1471-2466-7-13, 2096624, 17922919.
27. Tkacova R, McWilliams A, Lam S, Sin DD. Integrating lung and plasma expression of pneumo-proteins in developing biomarkers in COPD: a case study of surfactant protein D. Med Sci Monit 2010, 16:CR540-CR544.
28. Hoegh SV, Sorensen GL, Tornoe I, Lottenburger T, Ytting H, Nielsen HJ, Junker P, Holmskov U. Long-term stability and circadian variation in circulating levels of surfactant protein D. Immunobiology 2010, 215:314-320. 10.1016/j.imbio.2009.05.001, 19540617.
29. Madsen J, Kliem A, Tornoe I, Skjodt K, Koch C, Holmskov U. Localization of lung surfactant protein D on mucosal surfaces in human tissues. J Immunol 2000, 164:5866-5870.
30. Atochina-Vasserman EN, Beers MF, Gow AJ. Review: Chemical and structural modifications of pulmonary collectins and their functional consequences. Innate Immun 2010, 16:175-182. 10.1177/1753425910368871, 20423921.
31. Leth-Larsen R, Garred P, Jensenius H, Meschi J, Hartshorn K, Madsen J, Tornoe I, Madsen HO, Sorensen G, Crouch E, Holmskov U. A common polymorphism in the SFTPD gene influences assembly, function, and concentration of surfactant protein D. J Immunol 2005, 174:1532-1538.
32. Davies KJ, Delsignore ME, Lin SW. Protein damage and degradation by oxygen radicals. II. Modification of amino acids. J Biol Chem 1987, 262:9902-9907.
33. Walser T, Cui X, Yanagawa J, Lee JM, Heinrich E, Lee G, Sharma S, Dubinett SM. Smoking and lung cancer: the role of inflammation. Proc Am Thorac Soc 2008, 5:811-815. 10.1513/pats.200809-100TH, 19017734.
34. Rosell A, Monso E, Soler N, Torres F, Angrill J, Riise G, Zalacain R, Morera J, Torres A. Microbiologic determinants of exacerbation in chronic obstructive pulmonary disease. Arch Intern Med 2005, 165:891-897. 10.1001/archinte.165.8.891, 15851640.